SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jue Wang, Sheng Luo, Augmented Beta rectangular regression models: A Bayesian perspective, Biometrical Journal, 2015, 57, 4
  2. 2
    Fahd Baig, Michael Lawton, Michal Rolinski, Claudio Ruffmann, Kannan Nithi, Samuel G. Evetts, Hugo R. Fernandes, Yoav Ben-Shlomo, Michele T.M Hu, Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives, Movement Disorders, 2015, 30, 9
  3. 3
    Fabrizio Stocchi, Laura Vacca, Fabiana G Radicati, How to optimize the treatment of early stage Parkinson’s disease, Translational Neurodegeneration, 2015, 4, 1, 4

    CrossRef

  4. 4
    Danny Bega, Sheng Luo, Hubert Fernandez, Kelvin Chou, Michael Aminoff, Sotirios Parashos, Harrison Walker, David S. Russell, Chadwick W. Christine, Rohit Dhall, Carlos Singer, Ivan Bodis-Wollner, Robert Hamill, Daniel Truong, Zoltan Mari, Sofya Glazmann, Meilin Huang, Emily Houston, Tanya Simuni, Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease, Movement Disorders Clinical Practice, 2015, 2, 2
  5. 5
    John Y. Fang, Adriana Pérez, Chadwick W. Christine, Maureen Leehey, Michael J. Aminoff, James T. Boyd, John C. Morgan, Rohit Dhall, Anthony P. Nicholas, Ivan Bodis-Wollner, Richard M. Zweig, John L. Goudreau, Parkinson's disease severity and use of dopaminergic medications, Parkinsonism & Related Disorders, 2015, 21, 3, 297

    CrossRef

  6. 6
    Bruce Levin, The futility study—Progress over the last decade, Contemporary Clinical Trials, 2015,

    CrossRef

  7. 7
    Samantha Giordano, Victor Darley-Usmar, Jianhua Zhang, Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease, Redox Biology, 2014, 2, 82

    CrossRef

  8. 8
    Sheng Luo, Jue Wang, Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease, Statistics in Medicine, 2014, 33, 24
  9. 9
    LisaM Bond, Lisa McKerracher, Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements, Neural Regeneration Research, 2014, 9, 16, 1493

    CrossRef

  10. 10
    Radu Constantinescu, Jordan Elm, Peggy Auinger, Saloni Sharma, Erika F. Augustine, Laith Khadim, Karl Kieburtz, Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial, Movement Disorders, 2014, 29, 2
  11. 11
    Amaal AlDakheel, Lorraine V. Kalia, Anthony E. Lang, Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease, Neurotherapeutics, 2014, 11, 1, 6

    CrossRef

  12. You have free access to this content12
    Angelique Camilleri, Neville Vassallo, The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease, CNS Neuroscience & Therapeutics, 2014, 20, 7
  13. 13
    Konrad Szewczyk-Krolikowski, Paul Tomlinson, Kannan Nithi, Richard Wade-Martins, Kevin Talbot, Yoav Ben-Shlomo, Michele T.M. Hu, The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort, Parkinsonism & Related Disorders, 2014, 20, 1, 99

    CrossRef

  14. 14
    Dilan Athauda, Thomas Foltynie, The ongoing pursuit of neuroprotective therapies in Parkinson disease, Nature Reviews Neurology, 2014, 11, 1, 25

    CrossRef

  15. 15
    Rajnish K. Chaturvedi, M. Flint Beal, Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases, Molecular and Cellular Neuroscience, 2013, 55, 101

    CrossRef

  16. 16
    Sudhakar Raja Subramaniam, Marie-Francoise Chesselet, Mitochondrial dysfunction and oxidative stress in Parkinson's disease, Progress in Neurobiology, 2013, 106-107, 17

    CrossRef

  17. 17
    Fabrizio Stocchi, C. Warren Olanow, Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease, Movement Disorders, 2013, 28, 1
  18. 18
    Yousheng Xiao, Man Luo, Hongye Luo, Jin Wang, Creatine for Parkinson's disease, The Cochrane Library,